Search research articles
Contact Us
Filters
Showing results (201-210 of 216) with videos related to
Page
of 22
Sort By:
Leukemia Research
|
May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
JAMA Oncology
|
July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Simron Singh, Lesley Moody, David L Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
Prognostication of the high-risk WM patient
Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, et al.
American Journal of Hematology
|
April 22, 2011
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hatjiharissi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K Bergsland, Cynthia M Card, et al.
American Journal of Hematology
|
July 2, 2024
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group
Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
JAMA Oncology
|
November 13, 2025
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial
Matteo S Carlino, Bo Gao, Michael Michael, et al.
Annals of Hematology
|
October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 216) with videos related to
Sort By:
Page
of 22
Leukemia Research
|
May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
JAMA Oncology
|
July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Simron Singh, Lesley Moody, David L Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
Prognostication of the high-risk WM patient
Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, et al.
American Journal of Hematology
|
April 22, 2011
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hatjiharissi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K Bergsland, Cynthia M Card, et al.
American Journal of Hematology
|
July 2, 2024
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group
Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
JAMA Oncology
|
November 13, 2025
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial
Matteo S Carlino, Bo Gao, Michael Michael, et al.
Annals of Hematology
|
October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Page
of 22